These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38666296)

  • 41. Reporting rates for VAERS death reports following COVID-19 vaccination, December 14, 2020-November 17, 2021.
    Day B; Menschik D; Thompson D; Jankosky C; Su J; Moro P; Zinderman C; Welsh K; Dimova RB; Nair N
    Pharmacoepidemiol Drug Saf; 2023 Jul; 32(7):763-772. PubMed ID: 36813704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017.
    Bonaldo G; Vaccheri A; D'Annibali O; Motola D
    Br J Clin Pharmacol; 2019 Mar; 85(3):634-643. PubMed ID: 30569481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System.
    Nyankerh CNA; Boateng AK; Appah M
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.
    Varricchio F; Iskander J; Destefano F; Ball R; Pless R; Braun MM; Chen RT
    Pediatr Infect Dis J; 2004 Apr; 23(4):287-94. PubMed ID: 15071280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015.
    Myers TR; McNeil MM; Ng CS; Li R; Lewis PW; Cano MV
    Vaccine; 2017 Mar; 35(14):1758-1763. PubMed ID: 28262331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS).
    Braun MM; Mootrey GT; Salive ME; Chen RT; Ellenberg SS
    Pediatrics; 2000 Oct; 106(4):E51. PubMed ID: 11015546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse Events Following COVID-19 Vaccination in Adolescents: Insights From Pharmacovigilance Study of VigiBase.
    Kim DH; Kim JH; Oh IS; Choe YJ; Choe SA; Shin JY
    J Korean Med Sci; 2024 Mar; 39(8):e76. PubMed ID: 38442719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines.
    Sessa M; Kragholm K; Hviid A; Andersen M
    Expert Opin Drug Saf; 2021 Nov; 20(11):1451-1453. PubMed ID: 34264151
    [No Abstract]   [Full Text] [Related]  

  • 49. Stacking Ensemble of Disproportionality Indicators for Adverse Vaccine Reactions Detection-An Empirical Study on Predicting Adverse Reactions of COVID-19 Vaccines.
    Zhang BX; Lin WY; Huang TK
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38082660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of Sudden Sensorineural Hearing Loss After COVID-19 Vaccination.
    Formeister EJ; Wu MJ; Chari DA; Meek R; Rauch SD; Remenschneider AK; Quesnel AM; de Venecia R; Lee DJ; Chien W; Stewart CM; Galaiya D; Kozin ED; Sun DQ
    JAMA Otolaryngol Head Neck Surg; 2022 Apr; 148(4):307-315. PubMed ID: 35201274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Influence of the Rapid Increase in the Number of Adverse Event Reports for COVID-19 Vaccine on the Disproportionality Analysis Using JADER.
    Yamaoka K; Fujiwara M; Uchida M; Uesawa Y; Shimizu T
    In Vivo; 2023; 37(1):345-356. PubMed ID: 36593055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
    Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
    Front Immunol; 2021; 12():669010. PubMed ID: 34093567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. OAE-based data mining and modeling analysis of adverse events associated with three licensed HPV vaccines.
    Zi W; Yang Q; Su J; He Y; Xie J
    Heliyon; 2022 Nov; 8(11):e11515. PubMed ID: 36411908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines.
    Pareek M; Sessa P; Polverino P; Sessa F; Kragholm KH; Sessa M
    Front Cardiovasc Med; 2023; 10():1210007. PubMed ID: 38075965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013.
    Miller ER; Moro PL; Cano M; Lewis P; Bryant-Genevier M; Shimabukuro TT
    Vaccine; 2016 May; 34(25):2841-6. PubMed ID: 27087150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.
    Moro PL; Arana J; Marquez PL; Ng C; Barash F; Hibbs BF; Cano M
    Vaccine; 2019 Jun; 37(28):3730-3734. PubMed ID: 31155414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usefulness of Vaccine Adverse Event Reporting System for Machine-Learning Based Vaccine Research: A Case Study for COVID-19 Vaccines.
    Flora J; Khan W; Jin J; Jin D; Hussain A; Dajani K; Khan B
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A signal detection method for temporal variation of adverse effect with vaccine adverse event reporting system data.
    Cai Y; Du J; Huang J; Ellenberg SS; Hennessy S; Tao C; Chen Y
    BMC Med Inform Decis Mak; 2017 Jul; 17(Suppl 2):76. PubMed ID: 28699543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
    Kim JE; Park J; Min YG; Hong YH; Song TJ
    J Peripher Nerv Syst; 2022 Sep; 27(3):206-214. PubMed ID: 35751472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; DeStefano F; Iskander JK; Haber P; Chen RT;
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):505-10. PubMed ID: 15317028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.